Notificaciones OMC 133 Organización Mundial del Comercio JULIO BELICE Notificación: G/TBT/N/BLZ/8 Draft Belize Standard Specification for Labelling Part 3: Labelling of Prepackaged Food. This standard has been prepared in an effort to prevent fraud and deception arising from misleading labelling, as well as to provide adequate information to the consumer or user of prepackaged foods. All manufacturers, importers, distributors and other entities engaged in the production and or trade of pre-packaged food in Belize shall comply with the requirements of this standard. It is expected that this standard will assist Belize manufacturers in meeting the labelling requirements of regional and extra-regional markets. Objeto y razón de ser: Prevention of deceptive practices and consumer protection, Protection of animal or plant life or health, Quality requirements. BRASIL Notificación: G/TBT/N/BRA/738 Ordinance Nº. 30, 9 August 2017 (Instrução Normativa DIPOA/SDA Nº 30, 9 de Agosto de 2017). Ordinance establishing procedures for compulsory submission of proposal, evaluation, validation and implementation of technological innovations to be employed at any stage of products manufacturing of animal origin products in establishment for commercial production, registered in the Department of Inspection of Products of Animal Origin - DIPOA/Secretary of Agriculture and Livestock – SDA. Objeto y razón de ser: Quality requirements. ESTADOS UNIDOS Notificación: G/TBT/N/USA/1303 Manufactured Home Regulations; Request for Recommended Changes. Consistent with the National Manufactured Housing Construction and Safety Standards Act of 1974, as amended, this document invites interested persons to submit proposed changes to update and revise HUD’s Manufactured Home Construction and Safety Standards, its Manufactured Home Procedural and Enforcement Regulations, its Model Manufactured Home Installation Standards, and its Manufactured Home Installation Program regulations. Proposed changes will be submitted to the Manufactured Housing Consensus Committee (MHCC) for review and consideration as part of its responsibility to provide periodic recommendations to HUD to adopt, revise, and interpret the HUD standards and regulations. Objeto y razón de ser: Prevention of deceptive practices and consumer protection. MÉXICO Notificación: G/TBT/N/MEX/367 Norma Oficial Mexicana de Emergencia NOM-EM- 004-ASEA-2017; Especificaciones y requisitos en materia de seguridad industrial, seguridad operativa y protección al medio ambiente para el diseño, construcción, pre-arranque, operación, mantenimiento, cierre y desmantelamiento de estaciones de servicio con fin específico para el expendio al público de gas licuado de petróleo, por medio del llenado parcial o total de recipientes portátiles a presión. Aplica en todo el territorio nacional y es de observancia general y obligatoria para los Regulados que realicen el Diseño, Construcción, Pre-arranque, Operación, Mantenimiento, Cierre y Desmantelamiento de Estaciones de Servicio con Fin Específico para el Expendio al Público de Gas Licuado de Petróleo, por medio del llenado parcial o total de Recipientes Portátiles a presión. Objeto y razón de ser: Protection of the environment. SUIZA Notificación: G/TBT/N/CHE/222 Draft Ordinance on the Simplified Authorization Procedure and the Notification Procedure for Medicinal Products (VAZV) (18 pages, incl. additional annexes, available in German, French and Italian). Partial revision of the Ordinance on the Simplified Authorization Procedure and the Notification Procedure for Medicinal Products (VAZV). The VAZV contains the essential implementing provisions for the Articles 14 and 15 of the Therapeutic Products Act (TPA). The VAZV includes rules regarding admission and simplified authorization of medicinal products as so-called orphan drugs (important drugs for rare diseases: Art. 14 para. 1 let. f TPA). It also outlines rules on the simplified authorization procedure for medicinal products with known active pharmaceutical ingredients, hospital exemptions, and drugs manufactured by using a formula recognized by the Swiss Federal Agency for Therapeutic Products. Major proposed revisions are as follows: To introduce minor adjustments to the criteria for the designation of a medicinal product as an orphan medicinal product and to the rules of withdrawal of orphan designations; To implement new and simplified access opportunities for certain
normasaldia329
To see the actual publication please follow the link above